Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roland Schüle is active.

Publication


Featured researches published by Roland Schüle.


Journal of Biological Chemistry | 2004

The LIM-only proteins FHL2 and FHL3 interact with α- and β-subunits of the muscle α7β1 integrin receptor

Thomas Samson; Neil Smyth; Stefanie Janetzky; Olaf Wendler; Judith M. Müller; Roland Schüle; Helga von der Mark; Klaus von der Mark; Viktor Wixler

FHL1, FHL2, and FHL3 are members of the four and one-half LIM domain protein subclass that are expressed in striated muscles. Here we show that FHL2 and FHL3 are novel α7β1 integrin-interacting proteins. They bind both the α- and the β-subunit as well as different splice isoforms. The minimal binding sites for FHL2 and FHL3 on β1A-chain overlap, whereas on α7A and α7B subunits they are situated adjacent. Determining the binding sites for integrins on FHL2 or FHL3 revealed that the suprastructure of the whole molecule is important for these associations, rather than any single LIM domain. Immunofluorescence studies with cells expressing full-length FHL proteins or their deletion mutants showed that FHL2 and FHL3 but not FHL1 colocalize with integrins at cell adhesion sites. Further, their recruitment to the membrane results from binding to either the α- or the β-chain of the integrin receptor. The association of FHL2 or FHL3 with integrin receptors neither influences attachment of cells to different substrates nor changes their migration capacity. However, in cardiac and skeletal muscles, FHL2 and FHL3, respectively, are colocalized with α7β1 integrin receptor at the periphery of Z-discs, suggesting a role in mechanical stabilization of muscle cells.


Archive | 2010

Lysine-specific demethylase 1(lsd1) is a biomarker for breast cancer

Roland Schüle; Eric Metzger; Reinhard Büttner; Jutta Kirfel


Archive | 2010

Pharmaceutical composition containing inhibiting agents of protein methyltransferase i and use thereof to treat tumor diseases

Manfred Jung; Roland Schüle; Eric Metzger; Jürgen Liebscher; Michael Pätzel; Wolfgang Sippl


Archive | 2004

Modulation of osteoblast activity by fhl2

Roland Schüle; Thomas Günther; Judith Dr. Müller


Archive | 2010

Transgenic LSD1 animal model for cancer

Roland Schüle; Thomas Günther; Eric Metzger


Archive | 2011

Method of predicting the malignancy of prostate cancer by detecting the expression of the Protein Kinase C Related Kinase, PRK1

Roland Schüle; Eric Metzger


Archive | 2015

ANIMAL MODEL FOR TYPE 2 DIABETES AND OBESITY

Roland Schüle; Delphine Duteil; Eric Metzger; Thomas Günther


Archive | 2014

in Gastrointestinal Endocrine Cells for Transcriptional Activation by NeuroD1

Andrew B. Leiter; Subir K. Ray; H. Joyce Li; Eric Metzger; Roland Schüle


Archive | 2013

Modèle animal pour le diabète de type 2 et l'obésité

Roland Schüle; Delphine Duteil; Eric Metzger; Thomas Günther


Archive | 2010

Methods and compounds for the diagnosis and treatment of cancer

Eric Metzger; Roland Schüle

Collaboration


Dive into the Roland Schüle's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Pätzel

Humboldt University of Berlin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Klaus von der Mark

University of Erlangen-Nuremberg

View shared research outputs
Researchain Logo
Decentralizing Knowledge